SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-019354
Filing Date
2017-11-14
Accepted
2017-11-14 16:13:41
Documents
80
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20170930_10q.htm 10-Q 1079239
2 EXHIBIT 10.1 ex_100039.htm EX-10.1 207005
3 EXHIBIT 31.1 ex_99155.htm EX-31.1 9743
4 EXHIBIT 31.2 ex_99158.htm EX-31.2 10102
5 EXHIBIT 32.1 ex_99157.htm EX-32.1 4048
6 EXHIBIT 32.2 ex_99156.htm EX-32.2 3971
  Complete submission text file 0001437749-17-019354.txt   7327325

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nby-20170930.xml EX-101.INS 1573346
8 XBRL TAXONOMY EXTENSION SCHEMA nby-20170930.xsd EX-101.SCH 82977
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20170930_cal.xml EX-101.CAL 37265
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20170930_def.xml EX-101.DEF 539409
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20170930_lab.xml EX-101.LAB 432655
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20170930_pre.xml EX-101.PRE 558837
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 171201670
SIC: 2834 Pharmaceutical Preparations